Summary: A study using high-resolution biologgers has uncovered how environmental conditions significantly influence sleep patterns in wild boars. The research found that temperature, humidity, and snow cover impact sleep quality, efficiency, and duration. Warmer days reduced … [Read more...]
Incannex Sleep Apnea Drug Trial: Key Findings
Summary: Incannex Healthcare has completed dosing in a clinical trial evaluating the bioavailability and bioequivalence of IHL-42X, a combination drug candidate for treating obstructive sleep apnea. The trial compared the bioavailability of IHL-42X’s components, dronabinol and … [Read more...]
EMA Recommends Melatonin Drug for Children with Neurogenetic Disorders
Summary: The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended expanding the use of Slenyto, a prolonged-release melatonin drug, to treat insomnia in children with neurogenetic disorders. Originally approved in 2018 for children … [Read more...]
‘CPAP Mask of Choice’ Is Now OK for Medicare Beneficiaries
By Sree Roy In February 2024, the four Durable Medical Equipment Medicare Administrative Contractors (DME-MACs) issued a “Dear Physician” letter detailing recently established guidelines for completing a CPAP mask standard written order. “To promote patient adherence,” the … [Read more...]
Mouse Study Sheds Light on Sleep Apnea’s Role in Chronic Pain
Summary: A new study explores the link between obstructive sleep apnea (OSA) and chronic pain. The research found that hypoxia increases pain sensitivity by recruiting macrophages to sensory nerve tissues. This discovery highlights potential targets for treating pain in OSA … [Read more...]
Neurostimulator Developer StimAire Appoints Industry Vet as COO
Summary: StimAire, a company developing an injectable neurostimulator to treat obstructive sleep apnea (OSA), has appointed Arthur Rascon as its new chief operating officer (COO). Rascon brings over two decades of experience in the medical device industry, having previously held … [Read more...]
Daylight Saving Time Switch Linked to Unhealthy Habits
Summary: A study reveals that the onset of daylight saving time may lead to increased unhealthy behaviors, such as higher snack consumption and fewer visits to fitness centers. The study utilized social media data and real-time consumer behavior datasets to explore the impact of … [Read more...]
Brain Mechanisms Behind Sleep Apnea-Induced Hypertension ID’d
Summary: A University of Missouri study has uncovered that two neurochemicals, oxytocin and corticotropin-releasing hormone (CRH), cause overactivity in the brainstem during sleep apnea, which may lead to hypertension over time. The researchers say this discovery could lead to … [Read more...]
Fitbit Data Reveals Connections Between Sleep and Disease
Summary: A study using data from over 6,700 Fitbit users highlights the impact of sleep duration, quality, and consistency on various health outcomes. Conducted by researchers at Vanderbilt University Medical Center, the National Institute of Health’s All of Us Research Program, … [Read more...]
Sleep Monitoring Integrated into Phase 2 Obesity Drug Trial
Summary: Beacon Biosignals and Skye Bioscience are partnering to integrate sleep quality and sleep apnea endpoints in a phase 2 trial of obesity drug candidate Nimacimab. The trial will utilize sleep monitoring technology to provide an assessment of the drug’s impact on … [Read more...]
- « Previous Page
- 1
- …
- 29
- 30
- 31
- 32
- 33
- …
- 77
- Next Page »